Discovery Ventures

Discovery Ventures focuses on next-generation biotechnologies that address significant unmet medical needs in major disease areas. The firm invests in ground-breaking biomedical technologies such as gene therapy, advanced cell therapy, nanotechnology, bionics, AI, and big data to cure, prevent, or manage unsolved diseases. They are particularly interested in the confluence of big data, machine learning and healthcare, and the convergence of engineering and medicine. The firm targets companies owning the IP building blocks of next-generation technologies with therapeutic potential using innovative technologies that are likely first in class and of interest for acquisition by pharma. They focus on markets that are underserved, will achieve premium reimbursements, and have significant numbers of patients.